Extended curettage and adjuvant therapy for benign tumors of the talus

El-Moatasem, El-Hussien M.; Abdel-Rahman, Mohamed A.; Eid, Marc

doi:10.1016/j.foot.2015.02.002

Cited by 13 publications

(9 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our literature search yielded 38 observational studies [ 4 , 5 , 6 , 7 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 ] published between 1949 and 2016, which examined the outcome of cryosurgery in patients with giant cell tumours of the bone. Table 1 shows the detailed features of the included articles.…”

Section: Resultsmentioning

confidence: 99%

Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis

Sumari

Zin

Ismail

et al. 2022

Cancers

View full text Add to dashboard Cite

The challenge in the surgical treatment of giant cell tumours of bone is the relatively high recurrence rate after curettage alone. The use of a local adjuvant following curettage, on the other hand, has lowered the rate of recurrence. This systematic review and meta-analysis aimed to investigate the prevalence and risk of local recurrence of giant cell tumours of the bone after cryosurgery and the subsequent complications. Web of Science, Scopus, ScienceDirect, PubMed, and Google Scholar were searched to identify articles published until 13 October 2021. A random-effects model was used to examine the pooled prevalence and risk ratio (RR) of local recurrence in patients with giant cell tumours after cryosurgery with 95% confidence intervals (CIs). This study was registered with PROSPERO (CRD42020211620). A total of 1376 articles were identified, of which 38 studies (n = 1373, 46.2% male) were included in the meta-analysis. Following cryosurgery, the pooled prevalence of local recurrence in giant cell tumours was estimated as 13.5% [95% CI: 9.3–17.8, I2 = 63%], where European subjects exhibited the highest prevalence (24.2%). Compared to other local adjuvants. The RR of local recurrence following cryosurgery was 0.85 (95% CI: 0.63–1.17, I2 = 15%), which was not statistically significant compared to other local adjuvants. We found 3.9% fracture, 4.0% infection, 2.1% nerve injury, and 1.5% skin necrosis as the common complications. Based on the sensitivity analyses, this study is robust and reliable. This meta-analysis estimated a low prevalence of local recurrence of giant cell tumours with low complications following cryosurgery. Thus, it can be one of the adjuvant options for treating giant cell tumours.

show abstract

Section: Resultsmentioning

confidence: 99%

Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis

Sumari

Zin

Ismail

et al. 2022

Cancers

View full text Add to dashboard Cite

show abstract

“…There were no studies about talus-localized GCT in the literature, but there were case reports. [9,10] Sharma et al [9] reported total talectomy and arthrodesis after recurrence of a talus GCT of a 19-year-old male patient. Differently, El-Moatasem et al [10] did not observe recurrence for 40 months in patients who underwent curettage cryotherapy and grafting due to talus-localized GCT.…”

Section: Discussionmentioning

confidence: 99%

“…[9,10] Sharma et al [9] reported total talectomy and arthrodesis after recurrence of a talus GCT of a 19-year-old male patient. Differently, El-Moatasem et al [10] did not observe recurrence for 40 months in patients who underwent curettage cryotherapy and grafting due to talus-localized GCT. In our case series, the mean age of three GCT cases localized in the talus was 28 (range, 23 to 32) and the mean follow-up period was 109 (range, 96 to 124) months.…”

Section: Discussionmentioning

confidence: 99%

Management and retrospective analysis of tumors and tumor-like lesions localized in the talus

Karakoç

Ulucaköy

2021

Jt Dis Relat Surg

View full text Add to dashboard Cite

Objectives This study aims to investigate the characterization and follow-up results of tumors and tumor-like lesions in the talus. Patients and methods Twenty-one patients (15 males, 6 females; mean age: 31.6±17 years; range, 4 to 67 years) with benign and malignant tumors or tumor-like lesions in the talus region treated and followed in our clinic between January 2007 and January 2019 were evaluated retrospectively. Radiological, pathological, surgical, and demographic features were scanned from the database. Results Patients were followed for mean 80±45.1 (range, 25 to 156) months. The most common complaint was pain and antalgic gait. Benign bone tumors were found in 15 (71%) of 21 patients, while tumor-like lesions (two intraosseous ganglia, osteomyelitis, and bone infarction) were found in four patients. The remaining two were patients with lung and bladder cancer metastasis. Lesion size was mean 2.1±0.5 (range, 1.1 to 3.3) cm. Recurrence developed in 14.3% (n=3) of the patients during follow-up. Conclusion The talus is a rare location for tumors; however, benign and malignant tumors and tumor-like lesions may be localized in the talus.

show abstract

“…Several primary ABCs of the talus[ 2 , 4 - 6 ] and secondary ABCs on giant cell tumor[ 7 ] and Chondroblastoma[ 8 ] were described in the literature. Recurrence of ABC of the talus after curettage and bone grafting is extremely rare[ 5 , 6 ]. Surgical treatment of these lesions is essential to reduce the pain of the patient and to prevent the possibility of pathologic fracture.…”

Section: Introductionmentioning

confidence: 99%

Recurrent aneurysmal bone cyst of talus resulted in tibiotalocalcaneal arthrodesis

Vosoughi

Mozaffarian

Erfani

2017

WJCC

View full text Add to dashboard Cite

Aneurysmal bone cyst (ABC), a locally benign aggressive lytic lesion of either primary or secondary origin, seldom involves the talus. Herein, we present a 25-year-old man with recurrent ABC of the talus after curettage and bone grafting, which was managed by total resection followed by filling the defect using fibular graft and finally tibiotalocalcaneal arthrodesis due to articular surface involvement. At 18 mo postoperatively, no recurrence was detected. Arthrodesis might be a good option in cases with recurrent ABC of the talus especially with articular surface involvement.

show abstract

Extended curettage and adjuvant therapy for benign tumors of the talus

Cited by 13 publications

References 19 publications

Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis

Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis

Management and retrospective analysis of tumors and tumor-like lesions localized in the talus

Recurrent aneurysmal bone cyst of talus resulted in tibiotalocalcaneal arthrodesis

Contact Info

Product

Resources

About